aluates Reports

$ 0.0

Automative

Global Lipid Nanoparticle (LNP) Services Market Research Report 2026

Published Date: 2026-01-15

Report Code: QYRE-Auto-0L19497

Global Lipid Nanoparticle LNP Services Market Research Report 2025

BUY CHAPTERS

Global Lipid Nanoparticle (LNP) Services Market Research Report 2026

Code: QYRE-Auto-0L19497

Report

2026-01-15

Pages:197

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Precigenome

Creative-Biolabs

GenScript

ReciBioPharm

CD Bioparticles

Vernal Biosciences

Hzymes Biotech

LipExoGen

Merck

Cayman

Echelon

WuXi STA

Boc Sciences

Carcell

Cambridge Bioscience

FluidicLab

VectorBuilder

Helix Biotech

Guangzhou Anernor Biotechnology

Nanjing Yasmin Biotechnology

Evonik

FujiFilm Holdings

Ascendia Pharmaceuticals

Lipid Nanoparticle (LNP) Services Market Size

The global Lipid Nanoparticle (LNP) Services market was valued at US$ 1309 million in 2025 and is anticipated to reach US$ 2457 million by 2032, at a CAGR of 9.4% from 2026 to 2032.

Lipid Nanoparticle (LNP) Services Market

Lipid Nanoparticle (LNP) Services involve the development, production, and related technical support of lipid nanoparticles used in the pharmaceutical and biomedical fields. LNPs are stable nanoparticles composed of functional lipids, pegylated lipids, saturated phospholipids, and cholesterol. LNP Services aim to provide customized solutions for clients, covering the whole process from the early-stage research and development to large-scale production.

Lipid Nanoparticle (LNP) Services operate in a high-growth landscape defined by key trends, substantial opportunities, and persistent challenges: Core industry trends include the advancement of next-generation ionizable lipid formulations that boost delivery efficiency by 30-50% while reducing toxicity, the shift from contract research to integrated contract development and manufacturing organization (CDMO) platforms offering end-to-end solutions, the expansion of applications beyond mRNA vaccines to siRNA therapies, CRISPR gene editing, and personalized cancer vaccines, and the scaling of automated GMP manufacturing processes that increase throughput by 40% and minimize batch variability, alongside standardized regulatory frameworks from the FDA and EMA streamlining clinical development timelines. However, significant challenges persist, including high technical barriers that limit end-to-end manufacturing capabilities to just 15% of global CDMOs, stringent regulatory compliance increasing validation costs by 25-30%, supply chain vulnerabilities as key ionizable lipid production is concentrated in a handful of manufacturers, patent dominance by major players, technical limitations such as only 1-2% of siRNA escaping endosomes into the cytosol and poor non-hepatic tissue targeting, and ongoing safety concerns requiring extensive clinical data to gain regulatory approval and patient acceptance.

This report delivers a comprehensive overview of the global Lipid Nanoparticle (LNP) Services market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Lipid Nanoparticle (LNP) Services. The Lipid Nanoparticle (LNP) Services market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Lipid Nanoparticle (LNP) Services market comprehensively. Regional market sizes by Type, by Application, by Payload Type, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Lipid Nanoparticle (LNP) Services manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Lipid Nanoparticle (LNP) Services Market Report

Report Metric	Details
Report Name	Lipid Nanoparticle (LNP) Services Market
Accounted market size in 2025	US$ 1309 million
Forecasted market size in 2032	US$ 2457 million
CAGR	9.4%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Formulation Service Development Service Others
Segment by Payload Type	mRNA-LNP Services siRNA-LNP Services Other
Segment by Application	Drug Delivery Diagnostics Gene Therapy Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	PreciGenome, Creative Biolabs, Genscript, ReciBioPharm, CD Bioparticles, Vernal Biosciences, Hzymes Biotech, LipExoGen, Evonik, Merck, Cayman, Echelon, WuXi STA, BOC Sciences, Carcell, Cambridge Bioscience, FluidicLab, Guangzhou Anernor Biotechnology, Nanjing Yasmin Biotechnology, vectorbuilder, Helix Biotech, FUJIFILM Holdings, Ascendia Pharmaceuticals, Catalent, Polymun Scientific, Wacker, Corden Pharma, Cytiva, Croda International, Nippon Fine Chemical, Patheon, Lonza
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Payload Type, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Lipid Nanoparticle (LNP) Services companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Lipid Nanoparticle (LNP) Services Market growing?

Ans: The Lipid Nanoparticle (LNP) Services Market witnessing a CAGR of 9.4% during the forecast period 2026-2032.

What is the Lipid Nanoparticle (LNP) Services Market size in 2032?

Ans: The Lipid Nanoparticle (LNP) Services Market size in 2032 will be US$ 2457 million.

Who are the main players in the Lipid Nanoparticle (LNP) Services Market report?

Ans: The main players in the Lipid Nanoparticle (LNP) Services Market are PreciGenome, Creative Biolabs, Genscript, ReciBioPharm, CD Bioparticles, Vernal Biosciences, Hzymes Biotech, LipExoGen, Evonik, Merck, Cayman, Echelon, WuXi STA, BOC Sciences, Carcell, Cambridge Bioscience, FluidicLab, Guangzhou Anernor Biotechnology, Nanjing Yasmin Biotechnology, vectorbuilder, Helix Biotech, FUJIFILM Holdings, Ascendia Pharmaceuticals, Catalent, Polymun Scientific, Wacker, Corden Pharma, Cytiva, Croda International, Nippon Fine Chemical, Patheon, Lonza

What are the Application segmentation covered in the Lipid Nanoparticle (LNP) Services Market report?

Ans: The Applications covered in the Lipid Nanoparticle (LNP) Services Market report are Drug Delivery, Diagnostics, Gene Therapy, Others

What are the Type segmentation covered in the Lipid Nanoparticle (LNP) Services Market report?

Ans: The Types covered in the Lipid Nanoparticle (LNP) Services Market report are mRNA-LNP Services, siRNA-LNP Services, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Lipid Nanoparticle (LNP) Services Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Formulation Service

1.2.3 Development Service

1.2.4 Others

1.3 Market by Payload Type

1.3.1 Global Lipid Nanoparticle (LNP) Services Market Size Growth Rate by Payload Type: 2021 vs 2025 vs 2032

1.3.2 mRNA-LNP Services

1.3.3 siRNA-LNP Services

1.3.4 Other

1.4 Market by Targeting Capability

1.4.1 Global Lipid Nanoparticle (LNP) Services Market Size Growth Rate by Targeting Capability: 2021 vs 2025 vs 2032

1.5 Market by Application

1.5.1 Global Lipid Nanoparticle (LNP) Services Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Drug Delivery

1.5.3 Diagnostics

1.5.4 Gene Therapy

1.5.5 Others

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Lipid Nanoparticle (LNP) Services Market Perspective (2021–2032)

2.2 Global Lipid Nanoparticle (LNP) Services Growth Trends by Region

2.2.1 Global Lipid Nanoparticle (LNP) Services Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Lipid Nanoparticle (LNP) Services Historic Market Size by Region (2021–2026)

2.2.3 Lipid Nanoparticle (LNP) Services Forecasted Market Size by Region (2027–2032)

2.3 Lipid Nanoparticle (LNP) Services Market Dynamics

2.3.1 Lipid Nanoparticle (LNP) Services Industry Trends

2.3.2 Lipid Nanoparticle (LNP) Services Market Drivers

2.3.3 Lipid Nanoparticle (LNP) Services Market Challenges

2.3.4 Lipid Nanoparticle (LNP) Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Lipid Nanoparticle (LNP) Services Players by Revenue

3.1.1 Global Top Lipid Nanoparticle (LNP) Services Players by Revenue (2021–2026)

3.1.2 Global Lipid Nanoparticle (LNP) Services Revenue Market Share by Players (2021–2026)

3.2 Global Top Lipid Nanoparticle (LNP) Services Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Lipid Nanoparticle (LNP) Services Revenue

3.4 Global Lipid Nanoparticle (LNP) Services Market Concentration Ratio

3.4.1 Global Lipid Nanoparticle (LNP) Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Lipid Nanoparticle (LNP) Services Revenue in 2025

3.5 Global Key Players of Lipid Nanoparticle (LNP) Services Head Offices and Areas Served

3.6 Global Key Players of Lipid Nanoparticle (LNP) Services, Products and Applications

3.7 Global Key Players of Lipid Nanoparticle (LNP) Services, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Lipid Nanoparticle (LNP) Services Breakdown Data by Type

4.1 Global Lipid Nanoparticle (LNP) Services Historic Market Size by Type (2021–2026)

4.2 Global Lipid Nanoparticle (LNP) Services Forecasted Market Size by Type (2027–2032)

5 Lipid Nanoparticle (LNP) Services Breakdown Data by Application

5.1 Global Lipid Nanoparticle (LNP) Services Historic Market Size by Application (2021–2026)

5.2 Global Lipid Nanoparticle (LNP) Services Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Lipid Nanoparticle (LNP) Services Market Size (2021–2032)

6.2 North America Lipid Nanoparticle (LNP) Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Lipid Nanoparticle (LNP) Services Market Size by Country (2021–2026)

6.4 North America Lipid Nanoparticle (LNP) Services Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Lipid Nanoparticle (LNP) Services Market Size (2021–2032)

7.2 Europe Lipid Nanoparticle (LNP) Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Lipid Nanoparticle (LNP) Services Market Size by Country (2021–2026)

7.4 Europe Lipid Nanoparticle (LNP) Services Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Lipid Nanoparticle (LNP) Services Market Size (2021–2032)

8.2 Asia-Pacific Lipid Nanoparticle (LNP) Services Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Lipid Nanoparticle (LNP) Services Market Size by Region (2021–2026)

8.4 Asia-Pacific Lipid Nanoparticle (LNP) Services Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Lipid Nanoparticle (LNP) Services Market Size (2021–2032)

9.2 Latin America Lipid Nanoparticle (LNP) Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Lipid Nanoparticle (LNP) Services Market Size by Country (2021–2026)

9.4 Latin America Lipid Nanoparticle (LNP) Services Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Lipid Nanoparticle (LNP) Services Market Size (2021–2032)

10.2 Middle East & Africa Lipid Nanoparticle (LNP) Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Lipid Nanoparticle (LNP) Services Market Size by Country (2021–2026)

10.4 Middle East & Africa Lipid Nanoparticle (LNP) Services Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 PreciGenome

11.1.1 PreciGenome Company Details

11.1.2 PreciGenome Business Overview

11.1.3 PreciGenome Lipid Nanoparticle (LNP) Services Introduction

11.1.4 PreciGenome Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.1.5 PreciGenome Recent Development

11.2 Creative Biolabs

11.2.1 Creative Biolabs Company Details

11.2.2 Creative Biolabs Business Overview

11.2.3 Creative Biolabs Lipid Nanoparticle (LNP) Services Introduction

11.2.4 Creative Biolabs Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.2.5 Creative Biolabs Recent Development

11.3 Genscript

11.3.1 Genscript Company Details

11.3.2 Genscript Business Overview

11.3.3 Genscript Lipid Nanoparticle (LNP) Services Introduction

11.3.4 Genscript Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.3.5 Genscript Recent Development

11.4 ReciBioPharm

11.4.1 ReciBioPharm Company Details

11.4.2 ReciBioPharm Business Overview

11.4.3 ReciBioPharm Lipid Nanoparticle (LNP) Services Introduction

11.4.4 ReciBioPharm Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.4.5 ReciBioPharm Recent Development

11.5 CD Bioparticles

11.5.1 CD Bioparticles Company Details

11.5.2 CD Bioparticles Business Overview

11.5.3 CD Bioparticles Lipid Nanoparticle (LNP) Services Introduction

11.5.4 CD Bioparticles Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.5.5 CD Bioparticles Recent Development

11.6 Vernal Biosciences

11.6.1 Vernal Biosciences Company Details

11.6.2 Vernal Biosciences Business Overview

11.6.3 Vernal Biosciences Lipid Nanoparticle (LNP) Services Introduction

11.6.4 Vernal Biosciences Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.6.5 Vernal Biosciences Recent Development

11.7 Hzymes Biotech

11.7.1 Hzymes Biotech Company Details

11.7.2 Hzymes Biotech Business Overview

11.7.3 Hzymes Biotech Lipid Nanoparticle (LNP) Services Introduction

11.7.4 Hzymes Biotech Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.7.5 Hzymes Biotech Recent Development

11.8 LipExoGen

11.8.1 LipExoGen Company Details

11.8.2 LipExoGen Business Overview

11.8.3 LipExoGen Lipid Nanoparticle (LNP) Services Introduction

11.8.4 LipExoGen Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.8.5 LipExoGen Recent Development

11.9 Evonik

11.9.1 Evonik Company Details

11.9.2 Evonik Business Overview

11.9.3 Evonik Lipid Nanoparticle (LNP) Services Introduction

11.9.4 Evonik Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.9.5 Evonik Recent Development

11.10 Merck

11.10.1 Merck Company Details

11.10.2 Merck Business Overview

11.10.3 Merck Lipid Nanoparticle (LNP) Services Introduction

11.10.4 Merck Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.10.5 Merck Recent Development

11.11 Cayman

11.11.1 Cayman Company Details

11.11.2 Cayman Business Overview

11.11.3 Cayman Lipid Nanoparticle (LNP) Services Introduction

11.11.4 Cayman Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.11.5 Cayman Recent Development

11.12 Echelon

11.12.1 Echelon Company Details

11.12.2 Echelon Business Overview

11.12.3 Echelon Lipid Nanoparticle (LNP) Services Introduction

11.12.4 Echelon Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.12.5 Echelon Recent Development

11.13 WuXi STA

11.13.1 WuXi STA Company Details

11.13.2 WuXi STA Business Overview

11.13.3 WuXi STA Lipid Nanoparticle (LNP) Services Introduction

11.13.4 WuXi STA Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.13.5 WuXi STA Recent Development

11.14 BOC Sciences

11.14.1 BOC Sciences Company Details

11.14.2 BOC Sciences Business Overview

11.14.3 BOC Sciences Lipid Nanoparticle (LNP) Services Introduction

11.14.4 BOC Sciences Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.14.5 BOC Sciences Recent Development

11.15 Carcell

11.15.1 Carcell Company Details

11.15.2 Carcell Business Overview

11.15.3 Carcell Lipid Nanoparticle (LNP) Services Introduction

11.15.4 Carcell Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.15.5 Carcell Recent Development

11.16 Cambridge Bioscience

11.16.1 Cambridge Bioscience Company Details

11.16.2 Cambridge Bioscience Business Overview

11.16.3 Cambridge Bioscience Lipid Nanoparticle (LNP) Services Introduction

11.16.4 Cambridge Bioscience Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.16.5 Cambridge Bioscience Recent Development

11.17 FluidicLab

11.17.1 FluidicLab Company Details

11.17.2 FluidicLab Business Overview

11.17.3 FluidicLab Lipid Nanoparticle (LNP) Services Introduction

11.17.4 FluidicLab Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.17.5 FluidicLab Recent Development

11.18 Guangzhou Anernor Biotechnology

11.18.1 Guangzhou Anernor Biotechnology Company Details

11.18.2 Guangzhou Anernor Biotechnology Business Overview

11.18.3 Guangzhou Anernor Biotechnology Lipid Nanoparticle (LNP) Services Introduction

11.18.4 Guangzhou Anernor Biotechnology Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.18.5 Guangzhou Anernor Biotechnology Recent Development

11.19 Nanjing Yasmin Biotechnology

11.19.1 Nanjing Yasmin Biotechnology Company Details

11.19.2 Nanjing Yasmin Biotechnology Business Overview

11.19.3 Nanjing Yasmin Biotechnology Lipid Nanoparticle (LNP) Services Introduction

11.19.4 Nanjing Yasmin Biotechnology Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.19.5 Nanjing Yasmin Biotechnology Recent Development

11.20 vectorbuilder

11.20.1 vectorbuilder Company Details

11.20.2 vectorbuilder Business Overview

11.20.3 vectorbuilder Lipid Nanoparticle (LNP) Services Introduction

11.20.4 vectorbuilder Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.20.5 vectorbuilder Recent Development

11.21 Helix Biotech

11.21.1 Helix Biotech Company Details

11.21.2 Helix Biotech Business Overview

11.21.3 Helix Biotech Lipid Nanoparticle (LNP) Services Introduction

11.21.4 Helix Biotech Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.21.5 Helix Biotech Recent Development

11.22 FUJIFILM Holdings

11.22.1 FUJIFILM Holdings Company Details

11.22.2 FUJIFILM Holdings Business Overview

11.22.3 FUJIFILM Holdings Lipid Nanoparticle (LNP) Services Introduction

11.22.4 FUJIFILM Holdings Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.22.5 FUJIFILM Holdings Recent Development

11.23 Ascendia Pharmaceuticals

11.23.1 Ascendia Pharmaceuticals Company Details

11.23.2 Ascendia Pharmaceuticals Business Overview

11.23.3 Ascendia Pharmaceuticals Lipid Nanoparticle (LNP) Services Introduction

11.23.4 Ascendia Pharmaceuticals Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.23.5 Ascendia Pharmaceuticals Recent Development

11.24 Catalent

11.24.1 Catalent Company Details

11.24.2 Catalent Business Overview

11.24.3 Catalent Lipid Nanoparticle (LNP) Services Introduction

11.24.4 Catalent Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.24.5 Catalent Recent Development

11.25 Polymun Scientific

11.25.1 Polymun Scientific Company Details

11.25.2 Polymun Scientific Business Overview

11.25.3 Polymun Scientific Lipid Nanoparticle (LNP) Services Introduction

11.25.4 Polymun Scientific Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.25.5 Polymun Scientific Recent Development

11.26 Wacker

11.26.1 Wacker Company Details

11.26.2 Wacker Business Overview

11.26.3 Wacker Lipid Nanoparticle (LNP) Services Introduction

11.26.4 Wacker Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.26.5 Wacker Recent Development

11.27 Corden Pharma

11.27.1 Corden Pharma Company Details

11.27.2 Corden Pharma Business Overview

11.27.3 Corden Pharma Lipid Nanoparticle (LNP) Services Introduction

11.27.4 Corden Pharma Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.27.5 Corden Pharma Recent Development

11.28 Cytiva

11.28.1 Cytiva Company Details

11.28.2 Cytiva Business Overview

11.28.3 Cytiva Lipid Nanoparticle (LNP) Services Introduction

11.28.4 Cytiva Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.28.5 Cytiva Recent Development

11.29 Croda International

11.29.1 Croda International Company Details

11.29.2 Croda International Business Overview

11.29.3 Croda International Lipid Nanoparticle (LNP) Services Introduction

11.29.4 Croda International Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.29.5 Croda International Recent Development

11.30 Nippon Fine Chemical

11.30.1 Nippon Fine Chemical Company Details

11.30.2 Nippon Fine Chemical Business Overview

11.30.3 Nippon Fine Chemical Lipid Nanoparticle (LNP) Services Introduction

11.30.4 Nippon Fine Chemical Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.30.5 Nippon Fine Chemical Recent Development

11.31 Patheon

11.31.1 Patheon Company Details

11.31.2 Patheon Business Overview

11.31.3 Patheon Lipid Nanoparticle (LNP) Services Introduction

11.31.4 Patheon Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.31.5 Patheon Recent Development

11.32 Lonza

11.32.1 Lonza Company Details

11.32.2 Lonza Business Overview

11.32.3 Lonza Lipid Nanoparticle (LNP) Services Introduction

11.32.4 Lonza Revenue in Lipid Nanoparticle (LNP) Services Business (2021–2026)

11.32.5 Lonza Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Precigenome

Creative-Biolabs

GenScript

ReciBioPharm

CD Bioparticles

Vernal Biosciences

Hzymes Biotech

LipExoGen

Merck

Cayman

Echelon

WuXi STA

Boc Sciences

Carcell

Cambridge Bioscience

FluidicLab

VectorBuilder

Helix Biotech

Guangzhou Anernor Biotechnology

Nanjing Yasmin Biotechnology

Evonik

FujiFilm Holdings

Ascendia Pharmaceuticals

List of Tables

Table 1. Global Lipid Nanoparticle (LNP) Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Formulation Service

Table 3. Key Players of Development Service

Table 4. Key Players of Others

Table 5. Global Lipid Nanoparticle (LNP) Services Market Size Growth Rate by Payload Type (US$ Million): 2021 vs 2025 vs 2032

Table 6. Key Players of mRNA-LNP Services

Table 7. Key Players of siRNA-LNP Services

Table 8. Key Players of Other

Table 9. Global Lipid Nanoparticle (LNP) Services Market Size Growth Rate by Targeting Capability (US$ Million): 2021 vs 2025 vs 2032

Table 10. Global Lipid Nanoparticle (LNP) Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 11. Global Lipid Nanoparticle (LNP) Services Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 12. Global Lipid Nanoparticle (LNP) Services Market Size by Region (US$ Million), 2021–2026

Table 13. Global Lipid Nanoparticle (LNP) Services Market Share by Region (2021–2026)

Table 14. Global Lipid Nanoparticle (LNP) Services Forecasted Market Size by Region (US$ Million), 2027–2032

Table 15. Global Lipid Nanoparticle (LNP) Services Market Share by Region (2027–2032)

Table 16. Lipid Nanoparticle (LNP) Services Market Trends

Table 17. Lipid Nanoparticle (LNP) Services Market Drivers

Table 18. Lipid Nanoparticle (LNP) Services Market Challenges

Table 19. Lipid Nanoparticle (LNP) Services Market Restraints

Table 20. Global Lipid Nanoparticle (LNP) Services Revenue by Players (US$ Million), 2021–2026

Table 21. Global Lipid Nanoparticle (LNP) Services Market Share by Players (2021–2026)

Table 22. Global Top Lipid Nanoparticle (LNP) Services Players by Tier (Tier 1, Tier 2, and Tier 3), based on Lipid Nanoparticle (LNP) Services Revenue, 2025

Table 23. Ranking of Global Top Lipid Nanoparticle (LNP) Services Companies by Revenue (US$ Million) in 2025

Table 24. Global 5 Largest Players Market Share by Lipid Nanoparticle (LNP) Services Revenue (CR5 and HHI), 2021–2026

Table 25. Global Key Players of Lipid Nanoparticle (LNP) Services, Headquarters and Area Served

Table 26. Global Key Players of Lipid Nanoparticle (LNP) Services, Products and Applications

Table 27. Global Key Players of Lipid Nanoparticle (LNP) Services, Date of General Availability (GA)

Table 28. Mergers and Acquisitions, Expansion Plans

Table 29. Global Lipid Nanoparticle (LNP) Services Market Size by Type (US$ Million), 2021–2026

Table 30. Global Lipid Nanoparticle (LNP) Services Revenue Market Share by Type (2021–2026)

Table 31. Global Lipid Nanoparticle (LNP) Services Forecasted Market Size by Type (US$ Million), 2027–2032

Table 32. Global Lipid Nanoparticle (LNP) Services Revenue Market Share by Type (2027–2032)

Table 33. Global Lipid Nanoparticle (LNP) Services Market Size by Application (US$ Million), 2021–2026

Table 34. Global Lipid Nanoparticle (LNP) Services Revenue Market Share by Application (2021–2026)

Table 35. Global Lipid Nanoparticle (LNP) Services Forecasted Market Size by Application (US$ Million), 2027–2032

Table 36. Global Lipid Nanoparticle (LNP) Services Revenue Market Share by Application (2027–2032)

Table 37. North America Lipid Nanoparticle (LNP) Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 38. North America Lipid Nanoparticle (LNP) Services Market Size by Country (US$ Million), 2021–2026

Table 39. North America Lipid Nanoparticle (LNP) Services Market Size by Country (US$ Million), 2027–2032

Table 40. Europe Lipid Nanoparticle (LNP) Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Europe Lipid Nanoparticle (LNP) Services Market Size by Country (US$ Million), 2021–2026

Table 42. Europe Lipid Nanoparticle (LNP) Services Market Size by Country (US$ Million), 2027–2032

Table 43. Asia-Pacific Lipid Nanoparticle (LNP) Services Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 44. Asia-Pacific Lipid Nanoparticle (LNP) Services Market Size by Region (US$ Million), 2021–2026

Table 45. Asia-Pacific Lipid Nanoparticle (LNP) Services Market Size by Region (US$ Million), 2027–2032

Table 46. Latin America Lipid Nanoparticle (LNP) Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 47. Latin America Lipid Nanoparticle (LNP) Services Market Size by Country (US$ Million), 2021–2026

Table 48. Latin America Lipid Nanoparticle (LNP) Services Market Size by Country (US$ Million), 2027–2032

Table 49. Middle East & Africa Lipid Nanoparticle (LNP) Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 50. Middle East & Africa Lipid Nanoparticle (LNP) Services Market Size by Country (US$ Million), 2021–2026

Table 51. Middle East & Africa Lipid Nanoparticle (LNP) Services Market Size by Country (US$ Million), 2027–2032

Table 52. PreciGenome Company Details

Table 53. PreciGenome Business Overview

Table 54. PreciGenome Lipid Nanoparticle (LNP) Services Product

Table 55. PreciGenome Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 56. PreciGenome Recent Development

Table 57. Creative Biolabs Company Details

Table 58. Creative Biolabs Business Overview

Table 59. Creative Biolabs Lipid Nanoparticle (LNP) Services Product

Table 60. Creative Biolabs Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 61. Creative Biolabs Recent Development

Table 62. Genscript Company Details

Table 63. Genscript Business Overview

Table 64. Genscript Lipid Nanoparticle (LNP) Services Product

Table 65. Genscript Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 66. Genscript Recent Development

Table 67. ReciBioPharm Company Details

Table 68. ReciBioPharm Business Overview

Table 69. ReciBioPharm Lipid Nanoparticle (LNP) Services Product

Table 70. ReciBioPharm Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 71. ReciBioPharm Recent Development

Table 72. CD Bioparticles Company Details

Table 73. CD Bioparticles Business Overview

Table 74. CD Bioparticles Lipid Nanoparticle (LNP) Services Product

Table 75. CD Bioparticles Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 76. CD Bioparticles Recent Development

Table 77. Vernal Biosciences Company Details

Table 78. Vernal Biosciences Business Overview

Table 79. Vernal Biosciences Lipid Nanoparticle (LNP) Services Product

Table 80. Vernal Biosciences Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 81. Vernal Biosciences Recent Development

Table 82. Hzymes Biotech Company Details

Table 83. Hzymes Biotech Business Overview

Table 84. Hzymes Biotech Lipid Nanoparticle (LNP) Services Product

Table 85. Hzymes Biotech Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 86. Hzymes Biotech Recent Development

Table 87. LipExoGen Company Details

Table 88. LipExoGen Business Overview

Table 89. LipExoGen Lipid Nanoparticle (LNP) Services Product

Table 90. LipExoGen Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 91. LipExoGen Recent Development

Table 92. Evonik Company Details

Table 93. Evonik Business Overview

Table 94. Evonik Lipid Nanoparticle (LNP) Services Product

Table 95. Evonik Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 96. Evonik Recent Development

Table 97. Merck Company Details

Table 98. Merck Business Overview

Table 99. Merck Lipid Nanoparticle (LNP) Services Product

Table 100. Merck Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 101. Merck Recent Development

Table 102. Cayman Company Details

Table 103. Cayman Business Overview

Table 104. Cayman Lipid Nanoparticle (LNP) Services Product

Table 105. Cayman Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 106. Cayman Recent Development

Table 107. Echelon Company Details

Table 108. Echelon Business Overview

Table 109. Echelon Lipid Nanoparticle (LNP) Services Product

Table 110. Echelon Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 111. Echelon Recent Development

Table 112. WuXi STA Company Details

Table 113. WuXi STA Business Overview

Table 114. WuXi STA Lipid Nanoparticle (LNP) Services Product

Table 115. WuXi STA Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 116. WuXi STA Recent Development

Table 117. BOC Sciences Company Details

Table 118. BOC Sciences Business Overview

Table 119. BOC Sciences Lipid Nanoparticle (LNP) Services Product

Table 120. BOC Sciences Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 121. BOC Sciences Recent Development

Table 122. Carcell Company Details

Table 123. Carcell Business Overview

Table 124. Carcell Lipid Nanoparticle (LNP) Services Product

Table 125. Carcell Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 126. Carcell Recent Development

Table 127. Cambridge Bioscience Company Details

Table 128. Cambridge Bioscience Business Overview

Table 129. Cambridge Bioscience Lipid Nanoparticle (LNP) Services Product

Table 130. Cambridge Bioscience Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 131. Cambridge Bioscience Recent Development

Table 132. FluidicLab Company Details

Table 133. FluidicLab Business Overview

Table 134. FluidicLab Lipid Nanoparticle (LNP) Services Product

Table 135. FluidicLab Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 136. FluidicLab Recent Development

Table 137. Guangzhou Anernor Biotechnology Company Details

Table 138. Guangzhou Anernor Biotechnology Business Overview

Table 139. Guangzhou Anernor Biotechnology Lipid Nanoparticle (LNP) Services Product

Table 140. Guangzhou Anernor Biotechnology Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 141. Guangzhou Anernor Biotechnology Recent Development

Table 142. Nanjing Yasmin Biotechnology Company Details

Table 143. Nanjing Yasmin Biotechnology Business Overview

Table 144. Nanjing Yasmin Biotechnology Lipid Nanoparticle (LNP) Services Product

Table 145. Nanjing Yasmin Biotechnology Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 146. Nanjing Yasmin Biotechnology Recent Development

Table 147. vectorbuilder Company Details

Table 148. vectorbuilder Business Overview

Table 149. vectorbuilder Lipid Nanoparticle (LNP) Services Product

Table 150. vectorbuilder Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 151. vectorbuilder Recent Development

Table 152. Helix Biotech Company Details

Table 153. Helix Biotech Business Overview

Table 154. Helix Biotech Lipid Nanoparticle (LNP) Services Product

Table 155. Helix Biotech Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 156. Helix Biotech Recent Development

Table 157. FUJIFILM Holdings Company Details

Table 158. FUJIFILM Holdings Business Overview

Table 159. FUJIFILM Holdings Lipid Nanoparticle (LNP) Services Product

Table 160. FUJIFILM Holdings Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 161. FUJIFILM Holdings Recent Development

Table 162. Ascendia Pharmaceuticals Company Details

Table 163. Ascendia Pharmaceuticals Business Overview

Table 164. Ascendia Pharmaceuticals Lipid Nanoparticle (LNP) Services Product

Table 165. Ascendia Pharmaceuticals Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 166. Ascendia Pharmaceuticals Recent Development

Table 167. Catalent Company Details

Table 168. Catalent Business Overview

Table 169. Catalent Lipid Nanoparticle (LNP) Services Product

Table 170. Catalent Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 171. Catalent Recent Development

Table 172. Polymun Scientific Company Details

Table 173. Polymun Scientific Business Overview

Table 174. Polymun Scientific Lipid Nanoparticle (LNP) Services Product

Table 175. Polymun Scientific Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 176. Polymun Scientific Recent Development

Table 177. Wacker Company Details

Table 178. Wacker Business Overview

Table 179. Wacker Lipid Nanoparticle (LNP) Services Product

Table 180. Wacker Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 181. Wacker Recent Development

Table 182. Corden Pharma Company Details

Table 183. Corden Pharma Business Overview

Table 184. Corden Pharma Lipid Nanoparticle (LNP) Services Product

Table 185. Corden Pharma Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 186. Corden Pharma Recent Development

Table 187. Cytiva Company Details

Table 188. Cytiva Business Overview

Table 189. Cytiva Lipid Nanoparticle (LNP) Services Product

Table 190. Cytiva Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 191. Cytiva Recent Development

Table 192. Croda International Company Details

Table 193. Croda International Business Overview

Table 194. Croda International Lipid Nanoparticle (LNP) Services Product

Table 195. Croda International Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 196. Croda International Recent Development

Table 197. Nippon Fine Chemical Company Details

Table 198. Nippon Fine Chemical Business Overview

Table 199. Nippon Fine Chemical Lipid Nanoparticle (LNP) Services Product

Table 200. Nippon Fine Chemical Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 201. Nippon Fine Chemical Recent Development

Table 202. Patheon Company Details

Table 203. Patheon Business Overview

Table 204. Patheon Lipid Nanoparticle (LNP) Services Product

Table 205. Patheon Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 206. Patheon Recent Development

Table 207. Lonza Company Details

Table 208. Lonza Business Overview

Table 209. Lonza Lipid Nanoparticle (LNP) Services Product

Table 210. Lonza Revenue in Lipid Nanoparticle (LNP) Services Business (US$ Million), 2021–2026

Table 211. Lonza Recent Development

Table 212. Research Programs/Design for This Report

Table 213. Key Data Information from Secondary Sources

Table 214. Key Data Information from Primary Sources

Table 215. Authors List of This Report

List of Figures

Figure 1. Lipid Nanoparticle (LNP) Services Picture

Figure 2. Global Lipid Nanoparticle (LNP) Services Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Lipid Nanoparticle (LNP) Services Market Share by Type: 2025 vs 2032

Figure 4. Formulation Service Features

Figure 5. Development Service Features

Figure 6. Others Features

Figure 7. Global Lipid Nanoparticle (LNP) Services Market Size Comparison by Payload Type (US$ Million), 2021–2032

Figure 8. mRNA-LNP Services Features

Figure 9. siRNA-LNP Services Features

Figure 10. Other Features

Figure 11. Global Lipid Nanoparticle (LNP) Services Market Size Comparison by Targeting Capability (US$ Million), 2021–2032

Figure 12. Global Lipid Nanoparticle (LNP) Services Market Size by Application (US$ Million), 2021–2032

Figure 13. Global Lipid Nanoparticle (LNP) Services Market Share by Application: 2025 vs 2032

Figure 14. Drug Delivery Case Studies

Figure 15. Diagnostics Case Studies

Figure 16. Gene Therapy Case Studies

Figure 17. Others Case Studies

Figure 18. Lipid Nanoparticle (LNP) Services Report Years Considered

Figure 19. Global Lipid Nanoparticle (LNP) Services Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 20. Global Lipid Nanoparticle (LNP) Services Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 21. Global Lipid Nanoparticle (LNP) Services Market Share by Region: 2025 vs 2032

Figure 22. Global Lipid Nanoparticle (LNP) Services Market Share by Players in 2025

Figure 23. Global Lipid Nanoparticle (LNP) Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 24. The Top 10 and 5 Players Market Share by Lipid Nanoparticle (LNP) Services Revenue in 2025

Figure 25. North America Lipid Nanoparticle (LNP) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. North America Lipid Nanoparticle (LNP) Services Market Share by Country (2021–2032)

Figure 27. United States Lipid Nanoparticle (LNP) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Canada Lipid Nanoparticle (LNP) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Europe Lipid Nanoparticle (LNP) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Europe Lipid Nanoparticle (LNP) Services Market Share by Country (2021–2032)

Figure 31. Germany Lipid Nanoparticle (LNP) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. France Lipid Nanoparticle (LNP) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. U.K. Lipid Nanoparticle (LNP) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Italy Lipid Nanoparticle (LNP) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Russia Lipid Nanoparticle (LNP) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Ireland Lipid Nanoparticle (LNP) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Asia-Pacific Lipid Nanoparticle (LNP) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Asia-Pacific Lipid Nanoparticle (LNP) Services Market Share by Region (2021–2032)

Figure 39. China Lipid Nanoparticle (LNP) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Japan Lipid Nanoparticle (LNP) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. South Korea Lipid Nanoparticle (LNP) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Southeast Asia Lipid Nanoparticle (LNP) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. India Lipid Nanoparticle (LNP) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Australia & New Zealand Lipid Nanoparticle (LNP) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Latin America Lipid Nanoparticle (LNP) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Latin America Lipid Nanoparticle (LNP) Services Market Share by Country (2021–2032)

Figure 47. Mexico Lipid Nanoparticle (LNP) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Brazil Lipid Nanoparticle (LNP) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Middle East & Africa Lipid Nanoparticle (LNP) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Middle East & Africa Lipid Nanoparticle (LNP) Services Market Share by Country (2021–2032)

Figure 51. Israel Lipid Nanoparticle (LNP) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Saudi Arabia Lipid Nanoparticle (LNP) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. UAE Lipid Nanoparticle (LNP) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. PreciGenome Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 55. Creative Biolabs Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 56. Genscript Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 57. ReciBioPharm Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 58. CD Bioparticles Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 59. Vernal Biosciences Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 60. Hzymes Biotech Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 61. LipExoGen Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 62. Evonik Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 63. Merck Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 64. Cayman Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 65. Echelon Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 66. WuXi STA Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 67. BOC Sciences Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 68. Carcell Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 69. Cambridge Bioscience Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 70. FluidicLab Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 71. Guangzhou Anernor Biotechnology Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 72. Nanjing Yasmin Biotechnology Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 73. vectorbuilder Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 74. Helix Biotech Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 75. FUJIFILM Holdings Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 76. Ascendia Pharmaceuticals Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 77. Catalent Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 78. Polymun Scientific Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 79. Wacker Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 80. Corden Pharma Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 81. Cytiva Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 82. Croda International Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 83. Nippon Fine Chemical Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 84. Patheon Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 85. Lonza Revenue Growth Rate in Lipid Nanoparticle (LNP) Services Business (2021–2026)

Figure 86. Bottom-up and Top-down Approaches for This Report

Figure 87. Data Triangulation

Figure 88. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Lipid Contract Manufacturing Market Research Report 2024

Liposomal and Lipid based Nanoparticle Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Lipid Nanoparticle LNP Formulation Market Research Report 2024

Global Lipid Nanoparticle LNP Synthesis Services Market Research Report 2025

Global Lipid Nanoparticle LNP Formulation Service Market Research Report 2025

Global Lipid Nanoparticle LNP Development Service Market Research Report 2025

Global Lipid Nanoparticle LNP Production Equipment Market Research Report 2024

Global LNP Synthesis System Market Research Report 2024

Global Lipid Nanoparticle LNP Raw Material Market Research Report 2024

Global Lipid Nanoparticles LNP Market Research Report 2024

Global Lipid Nanoparticle CDMO Market Research Report 2025

Global Lipid Nanoparticle Synthesis System Market Research Report 2025

Global Polymer Nanoparticles PNP Formulation Development Market Research Report 2024

Global Lipid Nanoparticles LNPs CDMO Service Market Research Report 2024

Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Research Report 2024

Liposome and Lipid Nanoparticle Finished Pharmaceuticals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Liposome and Lipid Nanoparticle FDF Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global RNA LNP Lipid Nanoparticle Formulation Market Research Report 2024

Global Nanoparticle Drug Delivery Systems Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions